Hebei Weimiao Biology Co., LTD 1
Location
  • GW501516 CAS 317318-70-0 Supplier and Manufacturer Information and Details

Nov . 06, 2024 17:54 Back to list

GW501516 CAS 317318-70-0 Supplier and Manufacturer Information and Details



An Overview of GW501516 Manufacturer Insights and Applications


GW501516, also known by its CAS Number 317318-70-0, is a synthetic compound that belongs to a class of drugs known as peroxisome proliferator-activated receptor gamma (PPAR-γ) agonists. Originally developed in the late 1990s for the potential treatment of metabolic and cardiovascular diseases, it has garnered considerable attention in both scientific research and various industries, especially sports and fitness, for its metabolic-enhancing properties.


Manufacturers and Production of GW501516


The synthesis of GW501516 involves a multi-step chemical process, carried out by specialized chemical manufacturers. These manufacturers typically focus on producing high-purity compounds for research and therapeutic use. While there are numerous suppliers globally, the reputation of the manufacturer is crucial, as this can influence the quality and authenticity of the product. Reliable manufacturers adhere to strict quality control protocols and often provide Certificates of Analysis (CoA), which confirm the compound's purity and identity. This is particularly important in the research community, where discrepancies in compound quality can lead to invalid results.


Research and Applications


GW501516 has been extensively studied for its role in enhancing lipid metabolism and increasing endurance. Research has demonstrated that this compound activates PPARδ, which plays a critical role in regulating fatty acid metabolism and glucose homeostasis. As a result, GW501516 has drawn interest from the athletic community, as athletes seek to capitalize on its ability to improve stamina and overall performance.


gw501516 cas 317318-70-0 manufacturer

GW501516 CAS 317318-70-0 Supplier and Manufacturer Information and Details

Furthermore, GW501516 has been explored for its potential applications in managing conditions such as obesity, diabetes, and heart disease, due to its influence on metabolic pathways. Studies have shown that it can enhance fat oxidation and reduce body fat accumulation, making it a potential candidate for weight management therapies.


Safety and Regulatory Concerns


Despite its promising benefits, GW501516 is not without its controversies. The compound has faced scrutiny regarding its safety profile, particularly the long-term effects on human health. Initial animal studies indicated potential carcinogenic risks, leading to its discontinuation in clinical development for therapeutic use in humans. Consequently, it is essential for researchers and individuals using GW501516 to be aware of these potential risks and to consider the regulatory landscape in their respective countries.


Currently, GW501516 is classified as a prohibited substance by the World Anti-Doping Agency (WADA) due to its performance-enhancing properties. Athletes caught using this compound can face severe consequences, including bans and loss of titles. Therefore, while there is significant interest in the compound, its use in sports is highly discouraged.


Conclusion


In summary, GW501516 (CAS 317318-70-0) presents a complex profile balancing potential benefits and risks. Manufacturers of this compound play a vital role in ensuring purity and quality, thereby supporting ongoing research and application in various fields. As with any compound with significant biological activity, careful consideration of ethical, legal, and health issues is paramount. As researchers continue to explore the full breadth of GW501516’s capabilities, the scientific community remains vigilant regarding its implications for both human health and athletic performance.


Share

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


ms_MYMalay